MRD-guided Prognosis Prediction and Adjuvant Treatment Based on CTC and ctDNA in NSCLC

Clinical trial NCT06198868 · RECRUITING

Trial details

NCT number: NCT06198868
Sponsor: Jiangsu Cancer Institute & Hospital
Status: RECRUITING
Study type: OBSERVATIONAL

Non-small Cell Lung Cancer

Start date: 2024-02-01
Primary completion: 2026-02-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.